- 우선 이름
- 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile
- IUPAC
- 3-[(3R,4R)-3-[(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-methylamino]-4-methylpiperidin-1-yl]-3-oxopropanenitrile
- 영어명
- 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile
- 분자식
- C16H19ClN6O
- 분자량
- 346.81
이름 및 동의어
1616761-00-23-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrileN-Methyl-N-(3R,4R)-1-cyanoacetyl-4-methylpiperidin-3-yl-2-chloro-7-deazapurine-6-amine2-Chloro-tofacitinibTofacitinib Impurity 688J9ZSS3KKQMFCD269679713-[(3R,4R)-3-[(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-methylamino]-4-methylpiperidin-1-yl]-3-oxopropanenitrileTofacitinib Impurity 73-[(3R,4R)-3-({2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl}(methyl)amino)-4-methylpiperidin-1-yl]-3-oxopropanenitrile(3S,4S)-2-Chloro-Tofacitinib3-[(3R,4R)-3-[(2-Chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino]-4-methylpiperidin-1-yl]-3-oxopropanenitrile
이름 더 보기
Tofacitinib-20Tofatinib Impurity 16Tofacitinib Impurity 8Tofacitinib Impurity YTTofacitinib impurity PF-05087352Azilsartan medoxomil impurity336Tofacitinib citrate impurities VI3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)3-[3-[(2-Chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-methylamino]-4-methylpiperidin-1-yl]-3-oxopropanenitrile1-Piperidinepropanenitrile, 3-[(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-
UNII-8J9ZSS3KKQorb3181371SCHEMBL15861365DTXSID101109682CS-M2306RPC76100AKOS037647847AS-75015
데이터베이스 식별자
- PubChem CID
- 78358283
- DTXSID
DTXSID101109682- UNII
- 8J9ZSS3KKQ